CRTC1 and metabolic dysfunction-associated steatotic liver disease: Further, they highlight critical protective roles that CRTC1 selectively plays against NAFLD development and therapeutic potentials for targeting CRTC1 to selectively mediate beneficial metabolic effects of CR in the liver.